<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(1)</volume><submitter>Daum AK</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Targeted therapy interventions using tyrosine kinase inhibitors (TKIs) provide encouraging treatment responses in patients with ALK-rearranged lung adenocarcinomas, yet resistance occurs almost inevitably. In addition to tumor cell-intrinsic resistance mechanisms, accumulating evidence suggests that cancer-associated fibroblasts (CAFs) within the tumor microenvironment contribute to therapy resistance. This study aimed to investigate CAF-driven molecular networks that shape the therapeutic susceptibility of ALK-driven lung adenocarcinoma cells.&lt;h4>Methods&lt;/h4>Three-dimensional (3D) spheroid co-cultures comprising ALK-rearranged lung adenocarcinoma cells and CAFs were utilized to model the tumor microenvironment. Single-cell RNA sequencing was performed to uncover transcr</pubmed_abstract><journal>Cancer &amp; metabolism</journal><pagination>28</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12168422</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma cells by upregulating lipid biosynthesis.</pubmed_title><pmcid>PMC12168422</pmcid><pubmed_authors>Thomas M</pubmed_authors><pubmed_authors>Muley T</pubmed_authors><pubmed_authors>Klingmuller U</pubmed_authors><pubmed_authors>Sultmann H</pubmed_authors><pubmed_authors>Daum AK</pubmed_authors><pubmed_authors>Schulze A</pubmed_authors><pubmed_authors>Schneider MA</pubmed_authors><pubmed_authors>Schlicker L</pubmed_authors><pubmed_authors>Christopoulos P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma cells by upregulating lipid biosynthesis.</name><description>&lt;h4>Background&lt;/h4>Targeted therapy interventions using tyrosine kinase inhibitors (TKIs) provide encouraging treatment responses in patients with ALK-rearranged lung adenocarcinomas, yet resistance occurs almost inevitably. In addition to tumor cell-intrinsic resistance mechanisms, accumulating evidence suggests that cancer-associated fibroblasts (CAFs) within the tumor microenvironment contribute to therapy resistance. This study aimed to investigate CAF-driven molecular networks that shape the therapeutic susceptibility of ALK-driven lung adenocarcinoma cells.&lt;h4>Methods&lt;/h4>Three-dimensional (3D) spheroid co-cultures comprising ALK-rearranged lung adenocarcinoma cells and CAFs were utilized to model the tumor microenvironment. Single-cell RNA sequencing was performed to uncover transcr</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jun</publication><modification>2026-06-02T22:38:15.722Z</modification><creation>2026-04-21T03:13:47.899Z</creation></dates><accession>S-EPMC12168422</accession><cross_references><pubmed>40524253</pubmed><doi>10.1186/s40170-025-00400-7</doi></cross_references></HashMap>